← All trials
NCT01143025
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2010
- Primary completion
- Apr 1, 2011
- Completion date
- May 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 165
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- San Gerardo HospitalLead sponsor
- Azienda USL della Valle d'AostaCollaborator
- U.O.C. Anestesia e Rianimazione. Ospedale di Ponte San Pietro. BergamoStudy chair
- Azienda USL della Valle d'AostaStudy chair
- University of PadovaStudy chair
- University of PaviaCollaborator
- University of PadovaCollaborator
- University of PaviaStudy chair
- University of MilanCollaborator
- University of BresciaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.